Karolinska Development AB (publ) (STO: KDEV)
Sweden
· Delayed Price · Currency is SEK 1.042
-0.042 (-3.87%)
Nov 22, 2024, 5:24 PM CET
Karolinska Development AB Revenue
Karolinska Development AB had revenue of 387.00K SEK in the quarter ending September 30, 2024, a decrease of -6.07%. This brings the company's revenue in the last twelve months to 1.88M, down -8.08% year-over-year. In the year 2023, Karolinska Development AB had annual revenue of 2.01M, down -12.43%.
Revenue (ttm)
1.88M
Revenue Growth
-8.08%
P/S Ratio
149.73
Revenue / Employee
234.75K
Employees
8
Market Cap
281.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.01M | -286.00K | -12.43% |
| Dec 31, 2022 | 2.30M | 130.00K | 5.99% |
| Dec 31, 2021 | 2.17M | -481.00K | -18.14% |
| Dec 31, 2020 | 2.65M | -733.00K | -21.66% |
| Dec 31, 2019 | 3.38M | 311.00K | 10.12% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |
Karolinska Development AB News
- 8 days ago - Karolinska Development’s portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO - Business Upturn